Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation
{{output}}
The prevalence of prostate cancer emphasizes the need for improved therapeutic options, particularly for metastatic disease. Current treatment includes medical or surgical castration, which initially induces apoptosis of prostate cancer cells, but ultimately a... ...
